Colorectal Cancer Therapeutics strategies and Product Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Colorectal Cancer Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.

Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness in the anal area

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The common signs and symptoms of rectal cancer include a change in bowel habits, diarrhea, constipation, or feeling that the bowel does not empty completely, blood, either bright red or very dark in the stool, stools that are narrower than usual, general abdominal discomfort such as frequent gas pains, bloating, fullness or cramps, weight loss with no known reason, constant tiredness and vomiting.

Finally, colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason.

The size of these pipelines ranges from 10 products in rectal cancer to 581 products in colorectal cancer. Across all three of these indications, however, kinases, immune-related proteins, DNA-related proteins and viral proteins are common targets, closely reflecting the current treatment landscape of these diseases.

Scope
- Which companies are the most active within the pipeline for colorectal cancer therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of colorectal cancer?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Colorectal Cancer Report Coverage 11
2.2 Anal Cancer - Overview 11
2.3 Rectal Cancer - Overview 11
2.4 Colorectal Cancer - Overview 11
3 Therapeutics Development 12
3.1 Anal Cancer 12
3.2 Rectal Cancer 16
3.3 Colorectal Cancer 18
4 Therapeutics Assessment 56
4.1 Anal Cancer 56
4.2 Rectal Cancer 63
4.3 Colorectal Cancer 71
5 Companies Involved in Therapeutics Development 100
5.1 Anal Cancer 100
5.2 Rectal Cancer 108
5.3 Colorectal Cancer 114
6 Dormant Projects 241
6.1 Anal Cancer 241
6.2 Rectal Cancer 241
6.3 Colorectal Cancer 242
7 Discontinued Products 261
7.1 Anal Cancer 261
7.2 Colorectal Cancer 261
8 Product Development Milestones 265
8.1 Anal Cancer 265
8.2 Rectal Cancer 278
8.3 Colorectal Cancer 280
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/colorectal-cancer-therapeutics-strategies-and-product-pipeline-review-2017/250073

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250073

More News From thebudgetreport.com

King's legacy still felt strongly as Thailand bids goodbye

Oct 21, 2017

HUAY HOM, Thailand — Half a century has passed and the king is dead, but the villagers of Huay Hom still haven't forgotten the day Bhumibol Adulyadej descended by helicopter into their remote, impoverished mountain valley in northern Thailand and changed their lives forever. The king, they recall, brought electricity and a road that replaced the trail they trudged over for eight hours to reach the nearest roadhead. Coffee growing was greatly expanded and soon supplanted opium harvests, reaching such high quality that Starbucks is now a steady customer. The village even reaped profits from the royal-assisted raising of sheep...

No distress call after fishing boat with foreign crew wrecks

Oct 21, 2017

HONOLULU — A boat that ran aground off Honolulu while transporting foreign fishermen to work in Hawaii's commercial fishing industry has raised new questions about the safety and working conditions for foreign laborers in this unique U.S. fleet. A long, cramped journey to the United States for a group of fishermen from Vietnam, Indonesia, Philippines and Kiribati ended with a U.S. Coast Guard rescue last week after their fishing vessel smashed into a reef just off Waikiki's shore. No one aboard the boat called for help after the crash. A 2016 Associated Press investigation revealed the Hawaii fleet exploits a...

At GE, a new urgency to return to industrial roots

Oct 21, 2017

NEW YORK — General Electric's new CEO is starting to lay out bold plans to return the conglomerate to its industrial roots by slashing costs and streamlining its operations. John Flannery said Friday that the company will shed business units worth more than $20 billion over the next year or two. Flannery, who has been on the job less than three months, is expected to provide more details next month on how he will put his own stamp on the Boston-based manufacturing giant. But he offered plenty of hints after GE's latest disappointing financial results. GE drastically cut expectations for...

Power to the people: 2 Italy regions to hold autonomy votes

Oct 21, 2017

VERONA, Italy — It is greater autonomy __ not independence __ that two of Italy's wealthiest regions are seeking in a pair of referendums Sunday, yet Catalonia's secessionist ambitions in nearby Spain loom large over the debate. While the presidents of Lombardy and Veneto in northern Italy are campaigning on the economic benefits of loosening Rome's grip, identity politics also is playing a role, particularly in Veneto, heir to the once-vast Venetian Republic, where a political fringe has never given up on secession even though that's been long abandoned by the governing Northern League party. Both Veneto President Luca Zaia...

Spanish PM to unveil measures to fight Catalan separatists

Oct 21, 2017

BARCELONA, Spain — Spain's prime minister says his government will unveil specific measures Saturday to halt Catalonia's independence bid but refused to confirm if that included plans to hold a regional election in January. The opposition Socialists are supporting the conservative government's effort to rein in the country's deepest political crisis in decades. The Socialists' main negotiator, Carmen Calvo, said earlier Friday that an early election in the prosperous northeastern region of Catalonia had been agreed upon as part of the deal. Prime Minister Mariano Rajoy, commenting on the unprecedented constitutional step his government is taking to assume control of...